Clinical Trial Update: Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of Selinexor in patients with abiraterone and/or enzalutamide refractory metastatic castration-resistant prostate cancer; the study was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: University of California, San Francisco | Conditions: Castration Levels of Testosterone, Hormone-Resistant Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-06-26